Exchange: OTC·Updated 03:55 PM EDT

ELTP Elite Pharmaceuticals, Inc.

$0.258
$0.0031
(1.19%)
Today
EarningsNov 12
Mkt Cap$277.9M
Vol2.03M

About ELTP

Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the following segments: Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
35

Bearish Sentiment

How do you feel about ELTP?

Advertisement|Remove ads.